Document is current
Any future updates will be listed below
-
Authors
Neeland, Ian J.
Lim, Soo https://orcid.org/0000-0002-4137-1671
Tchernof, André
Gastaldelli, Amalia https://orcid.org/0000-0003-2594-1651
Rangaswami, Janani
Ndumele, Chiadi E.
Powell-Wiley, Tiffany M. https://orcid.org/0000-0001-9488-4131
Després, Jean-Pierre https://orcid.org/0000-0002-5193-583X
- License Information
-
More Information
Article History
Accepted: 17 September 2024
First Online: 17 October 2024
Competing interests
: I.J.N. has received honoraria, consulting and speaker’s bureau fees from Boehringer Ingelheim/Lilly Alliance, consulting and speakers’ bureau fees from Bayer Pharmaceuticals, and has participated in scientific advisory boards for Lilly, Boehringer Ingelheim, Novo Nordisk and AMRA Medical. S.L. has been a member on advisory boards or has consulted with Novo Nordisk, and has also served on the speakers’ bureau of AstraZeneca, Boehringer Ingelheim, Abbott, LG Chem., Daewoong Pharmaceutical, Chong Kun Dang Pharmaceutical and Novo Nordisk. A.T. receives research funding from Johnson & Johnson, Medtronics, GI Windows and Biotwin for studies on obesity and bariatric surgery, and has acted as a consultant for Bausch Health, Novo Nordisk and Biotwin. A.G. has served as a consultant for Boehringer Ingelheim, Eli Lilly and Company, Metadeq Diagnostics; has participated on advisory boards for Boehringer Ingelheim, Merck Sharp & Dohme, Novo Nordisk, Metadeq Diagnostics and Pfizer; and has received speaker’s honoraria and other fees from Eli Lilly and Company, Merck Sharp & Dohme, Novo Nordisk and Pfizer. J.R. is on the speakers’ bureau of Boehringer Ingelheim and acts as a consultant (advisory boards) for Boehringer Ingelheim, Edwards LifeSciences, Procyrion Inc. and AstraZeneca. T.M.P.-W. is paid by the American Heart Association as an Associate Editor for <i>JAHA</i>. C.E.N. and J.-P.D. declare no competing interests.
